CURE is pleased to announce the election of Elizabeth Sullivan, M.S., to CURE’s Board of Directors.
Liz is currently Senior Director, R & D Operations at Alexion (New Haven, CT), where she provides business management and operational support to the Global Head of Research and Development. Liz is a member of the R&D Leadership, as well as the Strategy, Portfolio and Project Management Leadership teams.
Liz has over 25 years of experience in the pharmaceutical industry spanning from target identification through marketing authorization. Prior to joining Alexion, Liz held leadership roles with Vion Pharmaceuticals and Bayer Healthcare Pharmaceuticals.